Trial Profile
A study investigating pharmacokinetics of SENS-111 and it's effects in subjects with vertigo
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2016
Price :
$35
*
At a glance
- Drugs Seliforant (Primary)
- Indications Vertigo
- Focus Pharmacodynamics; Pharmacokinetics
- 27 Oct 2016 New trial record
- 06 Oct 2016 Results published in the Clinical Therapeutics